Low-grade serous ovarian cancer: State of the science.
Epithelial ovarian cancer
Low-grade serous carcinoma of the ovary
Low-grade serous carcinoma of the peritoneum
Journal
Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
29
10
2019
revised:
18
12
2019
accepted:
23
12
2019
pubmed:
24
1
2020
medline:
3
7
2020
entrez:
24
1
2020
Statut:
ppublish
Résumé
In January 2019, a group of basic, translational, and clinical investigators and patient advocates assembled in Miami, Florida, to discuss the current state of the science of low-grade serous carcinoma of the ovary or peritoneum-a rare ovarian cancer subtype that may arise de novo or following a diagnosis of serous borderline tumor. The purpose of the conference was to review current knowledge, discuss ongoing research by established researchers, and frame critical questions or issues for future directions. Following presentations and discussions, the primary objective was to initiate future collaborations, uniform database platforms, laboratory studies, and clinical trials to better understand this disease and to advance clinical care outside the boundaries of single academic institutions. This review summarizes the state of the science in five principal categories: epidemiology and patient outcomes, pathology, translational research, patient care and clinical trials, and patients' perspective.
Identifiants
pubmed: 31969252
pii: S0090-8258(19)31862-1
doi: 10.1016/j.ygyno.2019.12.033
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-725Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Overall, there are no conflicts of interest with regard to this article (individual COI are disclosed on COI forms).